Thermo Fisher Scentific(TMO.US)

Last Updated 19:00:00 ET
longbridge loading

Thermo Fisher Scientific Inc. Stock Rises Tuesday, Outperforms Market

MarketWatch Automated·
US
TMO
+1.31%
US
PBE
+0.11%
US
XHE
+0.66%
MarketWatch Automated·
US
TMO
+1.31%
US
PBE
+0.11%
US
XHE
+0.66%

06:39 ETGlobal Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG

prnewswire·
US
TMO
+1.31%
US
AVTR
+0.53%
US
BIB
+0.05%
prnewswire·
US
TMO
+1.31%
US
AVTR
+0.53%
US
BIB
+0.05%

10:30 ETCancer Biomarkers Market worth $54.48 billion by 2032 | MarketsandMarkets™

prnewswire·
US
RHHBY
+1.49%
US
TMO
+1.31%
US
ILMN
+0.12%
prnewswire·
US
RHHBY
+1.49%
US
TMO
+1.31%
US
ILMN
+0.12%

Do Wall Street Analysts Like Thermo Fisher Scientific Stock?

Barchart Option·
US
TMO
+1.31%
US
PBE
+0.11%
US
BBH
+0.68%
Barchart Option·
US
TMO
+1.31%
US
PBE
+0.11%
US
BBH
+0.68%

Thermo Fisher Scientific Inc. Stock Falls Friday, Underperforms Market

MarketWatch Automated·
US
TMO
+1.31%
US
FBT
+0.54%
US
IBB
+0.10%
MarketWatch Automated·
US
TMO
+1.31%
US
FBT
+0.54%
US
IBB
+0.10%

Sector Update: Healthcare Stocks Softer Friday Afternoon

Fidelity·
US
ALMS
+1.77%
US
DXCM
+2.86%
US
SPRY
-1.78%
Fidelity·
US
ALMS
+1.77%
US
DXCM
+2.86%
US
SPRY
-1.78%

10:30 ETNutraceutical Inspection Systems Market worth $0.94 billion by 2031 | MarketsandMarkets™

prnewswire·
US
MTD
-2.24%
US
TMO
+1.31%
US
XHE
+0.66%
prnewswire·
US
MTD
-2.24%
US
TMO
+1.31%
US
XHE
+0.66%

Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer | NUVB Stock News

StockTitan·
US
TMO
+1.31%
US
NUVB
+0.71%
US
IXJ
+0.79%
StockTitan·
US
TMO
+1.31%
US
NUVB
+0.71%
US
IXJ
+0.79%
© 2026 Longbridge｜Disclaimer